Koninklijke KPN N.V.
Koninklijke KPN N.V. (KKPNY) Financial Performance & Income Statement Overview
Explore the financials of Koninklijke KPN N.V. (KKPNY), including yearly and quarterly data on income, cash flow, and balance sheets.
Koninklijke KPN N.V. (KKPNY) Income Statement & Financial Overview
Review Koninklijke KPN N.V. KKPNY income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.41B | $1.42B | $1.38B | $1.37B |
| Cost of Revenue | $678.00M | $641.00M | $632.00M | $640.00M |
| Gross Profit | $736.00M | $779.00M | $743.00M | $731.00M |
| Gross Profit Ratio | $0.52 | $0.55 | $0.54 | $0.53 |
| R&D Expenses | $217.00M | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $215.00M | $0.00 |
| Operating Expenses | $405.00M | $412.00M | $601.00M | $452.00M |
| Total Costs & Expenses | $1.08B | $1.05B | $1.02B | $1.09B |
| Interest Income | $0.00 | $0.00 | $11.00M | $59.00M |
| Interest Expense | $0.00 | $0.00 | $71.00M | $0.00 |
| Depreciation & Amortization | $36.00M | $276.00M | $307.00M | $268.00M |
| EBITDA | $369.00M | $648.00M | $672.00M | $616.00M |
| EBITDA Ratio | $0.26 | $0.46 | $0.49 | $0.45 |
| Operating Income | $331.00M | $367.00M | $357.00M | $348.00M |
| Operating Income Ratio | $0.23 | $0.26 | $0.26 | $0.25 |
| Other Income/Expenses (Net) | -$61.00M | -$66.00M | -$63.00M | -$128.00M |
| Income Before Tax | $270.00M | $301.00M | $294.00M | $220.00M |
| Income Before Tax Ratio | $0.19 | $0.21 | $0.21 | $0.16 |
| Income Tax Expense | $55.00M | $70.00M | $67.00M | $46.00M |
| Net Income | $215.00M | $231.00M | $227.00M | $174.00M |
| Net Income Ratio | $0.15 | $0.16 | $0.17 | $0.13 |
| EPS | $0.04 | $0.05 | $0.06 | $0.04 |
| Diluted EPS | $0.06 | $0.05 | $0.06 | $0.04 |
| Weighted Avg Shares Outstanding | $4.30B | $4.62B | $3.78B | $4.28B |
| Weighted Avg Shares Outstanding (Diluted) | $3.89B | $4.62B | $3.78B | $4.04B |
The company's financials show resilient growth, with revenue advancing from $1.37B in Q1 2024 to $1.41B in Q4 2024. Gross profit remained healthy with margins at 52% in Q4 2024 compared to 53% in Q1 2024. Operating income hit $331.00M last quarter, sustaining a consistent 23% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $369.00M. Net income dropped to $215.00M, while earnings per share reached $0.04. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan